title: No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study.
abstract: OBJECTIVE
  Drugs that modulate neuronal transmission can influence motor recovery after stroke. Here, we tested if a single dose of levodopa could improve motor functions and change motor excitability in a group of chronic stroke patients.
  
  
  METHODS
  Ten patients > 6 months after their stroke participated in a placebo-controlled double-blind trial. On two different occasions, they received either 100 mg levodopa or placebo in a randomized order. After drug intake, they participated in one hour of physiotherapy aimed at an improvement of dexterity. Motor functions were tested by application of the Nine-Hole-Peg Test, a dynamometer measuring grip strength and the Action Research Arm Test. In addition, transcranial magnetic stimulation (TMS) was applied to study intracortical excitability, stimulus response curves and silent periods. TMS studies and motor function measurements were performed before drug intake, 45 minutes after drug ingestion and after the physiotherapy.
  
  
  RESULTS
  Compared to placebo, levodopa neither improved motor functions nor changed motor excitability as tested by TMS.
  
  
  CONCLUSIONS
  These findings suggests that a single levodopa dose is not sufficient to improve motor function in chronic stroke. However, it cannot be excluded that the lack of a beneficial effect is related to the small study sample.
authors.affiliation: Department of Neurology, University Medical Center Eppendorf, Hamburg, Germany. restemey@uke.uni-hamburg.de
authors.forename: C
authors.initials: C
authors.lastname: Restemeyer
authors.forename: C
authors.initials: C
authors.lastname: Weiller
authors.forename: J
authors.initials: J
authors.lastname: Liepert
mesh_terms: D000368:Aged; D002908:Chronic Disease; D018592:Cross-Over Studies; D015259:Dopamine Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects*; D010865:Pilot Projects; D020127:Recovery of Function / Q000187:drug effects; D020521:Stroke / Q000188:drug therapy* / Q000503:physiopathology*; D050781:Transcranial Magnetic Stimulation; D017211:Treatment Failure
chemical_list: D015259:Dopamine Agents; D007980:Levodopa